Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
2.150
+0.040 (1.90%)
Dec 5, 2025, 4:00 PM EST - Market closed
Entera Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 99 | 78 | 17 | 21 | 81 | 20 | |
| Market Cap Growth | 61.25% | 351.66% | -17.80% | -74.05% | 308.59% | -23.76% | |
| Enterprise Value | 90 | 71 | 10 | 7 | 54 | 13 | |
| Last Close Price | 2.15 | 2.12 | 0.60 | 0.73 | 2.81 | 1.08 | |
| PS Ratio | 795.11 | 431.41 | - | 156.95 | 141.91 | 54.33 | |
| PB Ratio | 6.44 | 9.66 | 1.67 | 1.79 | 3.59 | 2.64 | |
| P/TBV Ratio | 6.47 | 9.66 | 1.67 | 1.79 | 3.59 | 2.64 | |
| EV/Sales Ratio | 727.66 | 394.91 | - | 51.05 | 94.51 | 35.56 | |
| Debt / Equity Ratio | 0.01 | 0.03 | 0.04 | 0.01 | 0.01 | 0.06 | |
| Asset Turnover | 0.01 | 0.02 | - | 0.01 | 0.03 | 0.03 | |
| Quick Ratio | 5.46 | 7.47 | 10.10 | 9.36 | 7.93 | 4.81 | |
| Current Ratio | 10.83 | 7.63 | 10.32 | 9.58 | 8.01 | 4.95 | |
| Return on Equity (ROE) | -99.43% | -103.34% | -80.30% | -76.17% | -81.04% | -115.46% | |
| Return on Assets (ROA) | -53.80% | -56.64% | -44.65% | -43.06% | -42.77% | -52.83% | |
| Return on Capital (ROIC) | -60.93% | -62.64% | -49.13% | -48.52% | -49.57% | -69.25% | |
| Return on Capital Employed (ROCE) | -68.40% | -116.70% | -83.30% | -114.30% | -53.50% | -141.70% | |
| Earnings Yield | -10.93% | -12.22% | -51.42% | -62.15% | -15.04% | -56.56% | |
| FCF Yield | -7.19% | -8.73% | -42.38% | -59.65% | -11.21% | -53.50% | |
| Buyback Yield / Dilution | -25.17% | -29.79% | -0.69% | -10.23% | -41.90% | -51.62% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.